These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36536402)

  • 1. HNRNPC, a predictor of prognosis and immunotherapy response based on bioinformatics analysis, is related to proliferation and invasion of NSCLC cells.
    Gu Z; Yang Y; Ma Q; Wang H; Zhao S; Qi Y; Li Y
    Respir Res; 2022 Dec; 23(1):362. PubMed ID: 36536402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum-derived extracellular vesicles promote the growth and metastasis of non-small cell lung cancer by delivering the m6A methylation regulator HNRNPC through the regulation of DLGAP5.
    Shi S; Wu T; Ma Z; Zhang X; Xu K; Tian Q; Gao L; Yin X; Xu S; Yang S
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4639-4651. PubMed ID: 36175801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer.
    Liu X; Ma C; Liu H; Sun Z; Luo J
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2803-2814. PubMed ID: 35596010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F; Guan Y; Ma Y; Xue L; Zhang P; Yang X; Chong T
    Aging (Albany NY); 2021 Apr; 13(8):11919-11941. PubMed ID: 33952721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N6-methyladenosine with immune infiltration and PD-L1 in hepatocellular carcinoma: novel perspective to personalized diagnosis and treatment.
    Shi Y; Wang Y; Zhang W; Niu K; Mao X; Feng K; Zhang Y
    Front Endocrinol (Lausanne); 2023; 14():1153802. PubMed ID: 37469973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. M6A-related bioinformatics analysis reveals that HNRNPC facilitates progression of OSCC via EMT.
    Huang GZ; Wu QQ; Zheng ZN; Shao TR; Chen YC; Zeng WS; Lv XZ
    Aging (Albany NY); 2020 Jun; 12(12):11667-11684. PubMed ID: 32526707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer.
    Yan M; Sun L; Li J; Yu H; Lin H; Yu T; Zhao F; Zhu M; Liu L; Geng Q; Kong H; Pan H; Yao M
    J Exp Clin Cancer Res; 2019 Nov; 38(1):478. PubMed ID: 31775888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis and validation of m6A regulatory network: a novel circBACH2/has-miR-944/HNRNPC axis in breast cancer progression.
    Lv W; Tan Y; Xiong M; Zhao C; Wang Y; Wu M; Wu Y; Zhang Q
    J Transl Med; 2021 Dec; 19(1):527. PubMed ID: 34952600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The m6A reader HNRNPC predicts adverse prognosis and promotes the progression of colorectal cancer.
    Yu YM; Hu Y
    Technol Health Care; 2024; 32(3):1445-1453. PubMed ID: 37661903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
    Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
    Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer.
    Cheng Y; Li L; Wei X; Xu F; Huang X; Qi F; Zhang Y; Li X
    Cancer Sci; 2023 May; 114(5):1830-1845. PubMed ID: 36718950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit-induced long intergenic non-protein coding RNA 1833 N6-methyladenosine methylation promotes the non-small cell lung cancer progression via regulating heterogeneous nuclear ribonucleoprotein A2/B1 expression.
    Li D; Fu Z; Dong C; Song Y
    Bioengineered; 2022 Apr; 13(4):10493-10503. PubMed ID: 35441574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The m6A reader HNRNPC promotes glioma progression by enhancing the stability of IRAK1 mRNA through the MAPK pathway.
    Chen JJ; Lu TZ; Wang T; Yan WH; Zhong FY; Qu XH; Gong XC; Li JG; Tou FF; Jiang LP; Han XJ
    Cell Death Dis; 2024 Jun; 15(6):390. PubMed ID: 38830885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HNRNPC promotes estrogen receptor-positive breast cancer cell cycle by stabilizing WDR77 mRNA in an m6A-dependent manner.
    Xu W; Huang Z; Xiao Y; Li W; Xu M; Zhao Q; Yi P
    Mol Carcinog; 2024 May; 63(5):859-873. PubMed ID: 38353359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N6-methylation of RNA-bound adenosine regulator HNRNPC promotes vascular endothelial dysfunction in type 2 diabetes mellitus by activating the PSEN1-mediated Notch pathway.
    Cai Y; Chen T; Wang M; Deng L; Li C; Fu S; Xie K
    Diabetes Res Clin Pract; 2023 Mar; 197():110261. PubMed ID: 36681355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HNRNPC promotes collagen fiber alignment and immune evasion in breast cancer via activation of the VIRMA-mediated TFAP2A/DDR1 axis.
    Lian B; Yan S; Li J; Bai Z; Li J
    Mol Med; 2023 Aug; 29(1):103. PubMed ID: 37528369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HNRNPC mediates lymphatic metastasis of cervical cancer through m6A-dependent alternative splicing of FOXM1.
    Liu YY; Xia M; Chen ZB; Liao YD; Zhang CY; Yuan L; Pan YW; Huang H; Lu HW; Yao SZ
    Cell Death Dis; 2024 Oct; 15(10):732. PubMed ID: 39375330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma.
    Wang Y; Zhao X; Li J; Wang X; Hu W; Zhang X
    Technol Cancer Res Treat; 2022; 21():15330338221085373. PubMed ID: 35343834
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioinformatics analysis of the correlation between m6A RNA methylation regulators and the immune infiltration and prognosis of bladder cancer.
    Wu J; Wang X; Xu H; Tian J; Ji H; Zhu J; Guo H; Chen Z
    Ann Transl Med; 2022 Dec; 10(24):1386. PubMed ID: 36660722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.